Treatment refractory hypothyroidism as a result of excessive donation of plasma
- PDF / 172,652 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 16 Downloads / 125 Views
LETTER TO THE EDITOR
Treatment refractory hypothyroidism as a result of excessive donation of plasma Ayokunle T. Abegunde • Benjamin Mba Ambika Babu
•
Received: 20 November 2012 / Accepted: 7 January 2013 / Published online: 20 January 2013 Ó Springer Science+Business Media New York 2013
To the Editor, Treatment refractory hypothyroidism as a result of excessive donation of plasma has not been previously reported in the literature. A 43-year-old woman with past medical history of Grave’s disease and post thyroidectomy hypothyroidism was evaluated for treatment refractory hypothyroidism. She weighed 90 kg and was started on levothyroxine (150 mcg) 3 months after thyroidectomy. Two months after starting levothyroxine her thyroid profile rapidly improved toward normal (TSH 6.99 lU/mL, T4 1.52 ng/dL) and subsequently, her TSH began to rise and levothyroxine was gradually increased to 225 mcg over eleven months, however, her thyroid profile did not normalize (TSH 30.4 lU/mL, T4 0.79 ng/dL). Her other medication included Aspirin, Ergocalciferol, Pantoprazole, Calcium carbonate, and Diltiazem. Poor medication adherence, ineffective timing of medication with meals and concomitant use of medication with Calcium carbonate and Pantoprazole were ruled out as causes for sub-optimal treatment. Basic metabolic profile, complete blood count and urinalysis were within normal limits. Total protein and Albumin were low (6.1 and 3.1 g/dL) respectively and antimicrosomal and thyroglobulin antibodies were negative. She had no symptoms of diarrhea or food intolerance to suggest malabsorption. At this point the etiology of her persistently elevated TSH level was a mystery. Exploration
A. T. Abegunde (&) B. Mba Department of Internal Medicine, John H. Stroger Jr. Hospital of Cook County, 1900 W, Polk Street, Chicago, IL 60612, USA e-mail: [email protected] A. Babu Department of Endocrinology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL 60612, USA
123
of her ideas, concerns, and expectations revealed that she was going through a divorce, and was having financial difficulty, so she resorted to donating plasma for income. She wondered if donating plasma was somehow responsible for her lack of response to treatment. Further enquiry revealed that she was donating plasma twice weekly at different sites. She was advised to stop donating plasma for 6 months and repeat her TSH/T4 before her next appointment. Her thyroid hormone levels had normalized by the next appointment three months later with a trend toward over treatment at 5 months (Fig. 1) and her dose of levothyroxine was appropriately reduced. Persistently elevated TSH in patients on thyroxine replacement therapy can result from medication non-adherence, inadequate dosing, concomitant use of levothyroxine with meals, coffee, competing medications, coexisting medical conditions such as celiac disease, autoimmune gastritis, and rarely, interference of the TSH/T4 laboratory assay by rheumatoid factor and heterophil antibodies [1]. The recommended frequency of plasma don
Data Loading...
